The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.
MyChesCo on MSN3mon
Urgent FDA Recall: Medtronic Insulin Pumps Pose Serious Health Risks Due to Battery FailuresWASHINGTON, D.C. — The U.S. Food and Drug Administration has issued a Class I recall, the most serious type, on Medtronic’s ...
Medtronic's MiniMed 670G - the closest ... closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device ...
Medtronic has become ... in order to acquire one. The MiniMed 670G includes a sensor attached to the body to measure glucose levels under the skin and an insulin pump strapped to the body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results